At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

Friedrichshafen event claims it is now Europe’s biggest business aviation trade show ...

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

Qatar’s state oil giant QatarEnergy said on Wednesday (March 18, 2026) that “extensive damage” has been caused ‌after the Ras Laffan Industrial City was subjected to missile attacks, shortly ⁠after ...

Hotels across Ras Al Khaimah are reporting strong occupancy ahead of Eid Al Adha, driven by rising demand from UAE residents opting for short-haul staycations within driving distance, as travellers ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of drugs used to treat type 2 diabetes and, in some cases, obesity. GLP-1 RAs are very effective at lowering blood sugar levels. As an ...

The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly untouchable tumour targets. The experimental drug, daraxonrasib, disarms all ...